The purpose of the study is to evaluate the value of biomarkers in the diagnosis and risk stratification of patients with suspected pulmonary embolism.
Management of patients with acute pulmonary embolism is a serious problem. The rapid and accurate diagnosis and risk stratification of these patients is an important unmet clinical need. The aim of the study is to evaluate the value of biomarkers, alone or in combination, in the diagnosis and risk stratification of patients with suspected pulmonary embolism presenting to the emergency department.
Study Type
OBSERVATIONAL
Enrollment
480
Beijing Anzhen Hospital
Beijing, Beijing Municipality, China
RECRUITINGArea under the ROC curve of biomarkers for the diagnosis of PE
The ROC curve will be built, the area under the curve will be calculated with its confidence interval.
Time frame: 2 years
PE related death
Number of PE related death
Time frame: 7 days
Symptomatic recurrent venous thromboembolic events
Number of symptomatic recurrent venous thromboembolic event
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.